Synapse - Michael Morris

Results (580)

Implementation of universal germline genetic testing into standard of care for patients with prostate cancer: The time is now

Journal Article

Shore, N.; Nielsen, S. M.; Esplin, E. D.; Antonarakis, E. S.; Barata, P. C.; Beer, T. M.; Beltran, H.; Bryce, A.; Cookson, M. S.; Crawford, E. D.; more...
JCO Oncology Practice (2025)

Fulltext@MSK | Save

Quality of informed consent via telemedicine compared with in-person for clinical cancer research

Journal Article

Sternschuss, M.; Lattanzi, M.; Vertosick, E.; Austria, M.; Martin, S.; Regazzi, A.; Buckely, M. T.; Lengfellner, J.; Riely, G. J.; Solit, D. B.; more...
JCO Oncology Practice (2025)

Fulltext@MSK | Save

BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways

Journal Article

Hirani, R.; Nandakumar, S.; Zaman, N.; Prabhakaraalva, P.; King, S. A.; Kalidindi, T. M.; Ghale, R.; Rajanala, S. H.; Fidele, D. C.; De Stanchina, E.; more...
Cell Reports (2025)

Fulltext@MSK | Save

Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab

Journal Article

Nixon, A. B.; Liu, Y. M.; Yang, Q.; Luo, B.; Starr, M. D.; Brady, J. C.; Kelly, W. K.; Beltran, H.; Morris, M. J.; George, D. J.; more...
Prostate Cancer and Prostatic Diseases (2025)

Fulltext@MSK | Save

Defining the role of pragmatic clinical trials in cancer clinical research: Outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer

Journal Article

Cardoso Borges, F.; van der Graaf, W. T. A.; Saesen, R.; Aebi, S.; Amariutei, A. E.; Bekelman, J.; Gorlia, T.; Hulstaert, F.; Huys, I.; Kluetz, P.; more...
Lancet Oncology (2025)

Fulltext@MSK | Save

CONVERGE-01: Dosimetry, randomized dose optimization, dose escalation, and efficacy of ac-225 rosopatamab tetraxetan in participants with PSMA-positive castration-resistant prostate cancer

Meeting Abstract

Morris, M. J.; Kiess, A. P.; Nordquist, L.; Gupta, S.; George, D. J.; Messmann, R. A.; Kantoff, P. W.; Nauseef, J. T.; Bander, N. H.; Antonarakis, E. S.
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

A phase 1b/2 study evaluating the activity of tinengotinib in combination with androgen receptor pathway inhibitors (ARPIs) in patients with metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Abida, W.; Chen, Y.; McHugh, D. J.; Morris, M. J.; Wu, F.; Peng, P.; Hennessy, K.; Wang, H.; Fan, J.; Zaidi, S.
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Radical prostatectomy (RP) versus radiotherapy (RT) in high-risk prostate cancer (HR-PCa): Emulated randomized comparison with individual patient data (IPD) from two phase III randomized trials (RCTs)

Meeting Abstract

Roy, S.; Sun, Y. L.; Eastham, J. A.; Gleave, M.; Beltran, H.; Kishan, A. U.; Jia, A. Y.; Zaorsky, N. G.; Garcia, J. A.; Small, E. J.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Efficacy of (177)Lu-PSMA-617 with or without ARPIs for the treatment of mCRPC: VISION secondary analysis

Meeting Abstract

Yazdanpanah, O.; Calais, J.; Chi, K. N.; De Bono, J. S.; Deymann, S.; El-Haddad, G.; Herrmann, K.; Fizazi, K.; Gonzalez, D. O.; Kendi, A. T.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save

Association of baseline and on-treatment ctDNA fraction with clinical outcomes in patients with mCRPC in the PSMAfore study of (177)Lu-PSMA-617

Meeting Abstract

De Bono, J. S.; Morris, M. J.; Sartor, A. O.; Wei, X. X.; Fizazi, K.; Herrmann, K.; Piulats, J. M.; Mahammedi, H.; Logothetis, C.; George, D. J.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save